Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · Real-Time Price · USD
1.610
-0.060 (-3.59%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Myomo Revenue
Myomo had revenue of $11.70M in the quarter ending June 30, 2026, with 21.26% growth. This brings the company's revenue in the last twelve months to $43.26M, up 6.14% year-over-year. In the year 2025, Myomo had annual revenue of $40.93M with 25.73% growth.
Revenue (ttm)
$43.26M
Revenue Growth
+6.14%
P/S Ratio
1.47
Revenue / Employee
$221,856
Employees
195
Market Cap
63.77M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 40.93M | 8.38M | 25.73% |
| Dec 31, 2024 | 32.55M | 13.31M | 69.17% |
| Dec 31, 2023 | 19.24M | 3.69M | 23.70% |
| Dec 31, 2022 | 15.56M | 1.70M | 12.26% |
| Dec 31, 2021 | 13.86M | 6.27M | 82.72% |
| Dec 31, 2020 | 7.58M | 3.75M | 97.60% |
| Dec 31, 2019 | 3.84M | 1.39M | 57.02% |
| Dec 31, 2018 | 2.44M | 885.24K | 56.79% |
| Dec 31, 2017 | 1.56M | 455.59K | 41.29% |
| Dec 31, 2016 | 1.10M | 413.61K | 59.97% |
| Dec 31, 2015 | 689.67K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Outset Medical | 117.80M |
| Xtant Medical Holdings | 109.53M |
| Pulmonx | 87.44M |
| TELA Bio | 79.91M |
| CVRx, Inc. | 61.19M |
| LENSAR | 60.26M |
| Rapid Micro Biosystems | 35.18M |
| Sensus Healthcare | 17.51M |
MYO News
- 11 days ago - Myomo Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 13 days ago - Myomo management to meet virtually with Craig-Hallum - TheFly
- 26 days ago - Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Business Wire
- 4 weeks ago - Myomo price target raised to $10.50 from $10 at Ascendiant - TheFly
- 7 weeks ago - Myomo sees Q3 revenue $11.5M-$12M, consensus $11.16M - TheFly
- 7 weeks ago - Myomo sees FY26 revenue $45M-$47M, consensus $44.43M - TheFly
- 7 weeks ago - Myomo reports Q2 EPS (9c), consensus (10c) - TheFly
- 7 weeks ago - Myomo Earnings Call Transcript: Q2 2026 - Transcripts